Home/Filings/4/0001493152-23-022267
4//SEC Filing

Sax Adriann 4

Accession 0001493152-23-022267

CIK 0001310527other

Filed

Jun 22, 8:00 PM ET

Accepted

Jun 23, 4:30 PM ET

Size

7.8 KB

Accession

0001493152-23-022267

Insider Transaction Report

Form 4
Period: 2023-06-23
Sax Adriann
Director
Transactions
  • Award

    Common Stock

    2023-06-23+10,45510,455 total
Holdings
  • Options to buy common stock

    Exercise: $8.00Exp: 2032-01-25Common Stock (6,250 underlying)
    6,250
  • Options to buy common stock

    Exercise: $10.00Exp: 2032-03-03Common Stock (18,750 underlying)
    18,750
Footnotes (3)
  • [F1]This award of shares is being made pursuant to the Issuer's restricted stock award agreement and is subject to a vesting schedule, such that a portion or all of this award of restricted stock may be forfeited in the future if certain milestones are not met
  • [F2]The option vests annually in two equal installments beginning on 1/25/2023.
  • [F3]The option vests annually in two equal installments beginning on 3/3/2023.

Documents

1 file

Issuer

QSAM Biosciences, Inc.

CIK 0001310527

Entity typeother

Related Parties

1
  • filerCIK 0001910140

Filing Metadata

Form type
4
Filed
Jun 22, 8:00 PM ET
Accepted
Jun 23, 4:30 PM ET
Size
7.8 KB